- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: Drug-Pricing Collusion; NJ, Alaska Sue Over Opioids; Preterm Births in US
Drug-pricing collution lawsuit widens to include more companies and drugs; New Jersey and Alaska also file lawsuits against Purdue Pharma for opioid marketing tactics; and the preterm birth rate in the United States increases.
Drug-Pricing Collusion Lawsuit Widens
A lawsuit brought by state attorneys general accusing companies of drug-pricing collusion has increased the number of companies named as defendants and expanded the number of drugs.
that the lawsuit now accuses 18 companies and 15 medicines, in addition to targeting 2 individual executives at Mylan and Emcure Pharmaceuticals. The lawsuit claims the drug makers agreed on dividing up the market and sometimes on prices increases. The original complaint only targeted 6 companies and 2 drugs.
New Jersey and Alaska Also Sue Opioid Maker
The list of states and municipalities suing Purdue Pharma for misleading sales tactics for opioid painkillers has grown to include New Jersey and Alaska. Both states’ attorneys general accused the company of aggressive and misleading tactics that fueled the opioid and heroin addiction crisis, reported The Wall Street Journal. Purdue is also being sued by 9 other states, and New Jersey is also suing Insys Therapeutics for marketing of the painkiller Subsys, which was only approved to be marketed to cancer patients.
US Preterm Birth Rate Increases
For the second year, the preterm birth rate has risen in the United States following nearly a decade of declines. According to STAT, minorities are suffering a disproportionate share of preterm births and rates in some parts of the United States are similar to those in undeveloped countries in Africa and the Middle East. Compared with white women, black women were 49% more likely to give birth prematurely and American Indian and Native Alaskan women were 18% more likely. Cleveland had the highest preterm birth rate of 100 cities examined.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
